Vieworks Co., Ltd. (KOSDAQ:100120)
24,650
-50 (-0.20%)
May 13, 2025, 3:30 PM KST
Vieworks Revenue
In the year 2024, Vieworks had annual revenue of 222.90B KRW with 1.20% growth. Vieworks had revenue of 59.75B in the quarter ending December 31, 2024, a decrease of -4.39%.
Revenue
222.90B
Revenue Growth
+1.20%
P/S Ratio
1.02
Revenue / Employee
457.70M
Employees
487
Market Cap
226.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 222.90B | 2.65B | 1.20% |
Dec 31, 2023 | 220.25B | -17.68B | -7.43% |
Dec 31, 2022 | 237.93B | 44.79B | 23.19% |
Dec 31, 2021 | 193.14B | 32.88B | 20.51% |
Dec 31, 2020 | 160.26B | 24.25B | 17.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
HLB Co., Ltd. | 68.13B |
SK Biopharmaceuticals | 547.60B |
PharmaResearch | 350.12B |
Peptron | 3.15B |